Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Nanosonics stock price, quote, forecast and news

NAN.AX
AU000000NAN9
A0MQVE

Price

3.14
Today +/-
+0
Today %
+0 %
P

Nanosonics Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Nanosonics, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Nanosonics from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Nanosonics’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Nanosonics. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Nanosonics’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Nanosonics’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Nanosonics’s growth potential.

Nanosonics Revenue, EBIT and net profit per share

DateNanosonics RevenueNanosonics EBITNanosonics Net Income
2030e335.5 M undefined109 M undefined81.28 M undefined
2029e296.06 M undefined79.98 M undefined66.22 M undefined
2028e255.47 M undefined57.47 M undefined47.1 M undefined
2027e236.85 M undefined40.67 M undefined34.03 M undefined
2026e209.75 M undefined19.98 M undefined19.25 M undefined
2025e193.37 M undefined12.94 M undefined13.24 M undefined
2024e170.45 M undefined6.52 M undefined9.56 M undefined
2023165.99 M undefined17.79 M undefined19.88 M undefined
2022120.32 M undefined1.84 M undefined3.74 M undefined
2021103.08 M undefined9.78 M undefined8.58 M undefined
2020100.05 M undefined12.34 M undefined10.14 M undefined
201984.32 M undefined13.66 M undefined13.6 M undefined
201860.7 M undefined2.81 M undefined5.75 M undefined
201767.51 M undefined12.1 M undefined26.16 M undefined
201642.8 M undefined-370,000 undefined122,000 undefined
201522.21 M undefined-6.78 M undefined-5.46 M undefined
201421.49 M undefined-2.82 M undefined-2.61 M undefined
201314.9 M undefined-6.42 M undefined-5.77 M undefined
201212.3 M undefined-5.9 M undefined-4.68 M undefined
20112.25 M undefined-12.97 M undefined-11.21 M undefined
2010760,000 undefined-8.96 M undefined-8.17 M undefined
2009310,000 undefined-9.94 M undefined-8.75 M undefined
20083.06 M undefined-7.15 M undefined-7.15 M undefined
20072.86 M undefined-5.71 M undefined-5.71 M undefined
20062.46 M undefined-1.76 M undefined-1.76 M undefined
20051.41 M undefined-500,000 undefined-500,000 undefined

Nanosonics Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e2029e2030e
12230021214212242676084100103120165170193209236255296335
-100.00-50.00---500.0016.6750.004.7690.9159.52-10.4540.0019.053.0016.5037.503.0313.538.2912.928.0516.0813.18
---100.00--50.0058.3357.1461.9068.1876.1974.6375.0073.8175.0077.6775.8378.79-------
0003001781315325045627580911300000000
0-1-5-7-9-8-12-5-6-2-601221312911761219405779109
--50.00-250.00-233.33---600.00-41.67-42.86-9.52-27.27-17.913.3315.4812.008.740.8310.303.536.229.0916.9522.3526.6932.54
0-1-5-7-8-8-11-4-5-2-50265131083199131934476681
--400.0040.0014.29-37.50-63.6425.00-60.00150.00---80.77160.00-23.08-20.00-62.50533.33-52.6344.4446.1578.9538.2440.4322.73
100104.75133.76194.88196.28211.43227.18234.65261.2263.07269.53289.59300.72301.7303.11303.98305.16305.6306.290000000
--------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Nanosonics Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Nanosonics is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Nanosonics provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Nanosonics's financial health and stability.

Assets

Nanosonics's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Nanosonics must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Nanosonics after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Nanosonics's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2005200620072008200920102011201220132014201520162017201820192020202120222023
00000000000000008319
0000000000000000457
0000000000000000000
1123101122011111001
00000000000000004-22
0000000000000000000
00000000000000000-1-1
0-1-4-7-9-7-9-5-4-2-231694227623
0000-10-10-10-2-1-1-2-2-1-1-6-3
0000-10-10-10-2-1-1-2-2-1-1-6-3
0000000000000000000
0000000000000000000
000000070001000-1-1-2-2
06300015115002900000000
0630001512200281000-1-1-1-2
-------------------
0000000000000000000
-2118-17-21-1-1910-12-7215291464111640
-0.73-1.66-5.3-7.51-10.54-7.94-10.18-5.87-5.87-3.07-4.731.9215.126.192.5920.885.94-0.2719.74
0000000000000000000

Nanosonics stock margins

The Nanosonics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Nanosonics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Nanosonics.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Nanosonics's sales revenue. A higher gross margin percentage indicates that the Nanosonics retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Nanosonics's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Nanosonics's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Nanosonics's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Nanosonics. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Nanosonics's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Nanosonics Margin History

Nanosonics Gross marginNanosonics Profit marginNanosonics EBIT marginNanosonics Profit margin
2030e78.71 %32.49 %24.23 %
2029e78.71 %27.01 %22.37 %
2028e78.71 %22.5 %18.44 %
2027e78.71 %17.17 %14.37 %
2026e78.71 %9.53 %9.18 %
2025e78.71 %6.69 %6.84 %
2024e78.71 %3.83 %5.61 %
202378.71 %10.72 %11.98 %
202276.38 %1.53 %3.11 %
202177.98 %9.49 %8.32 %
202075.47 %12.33 %10.13 %
201974.49 %16.2 %16.13 %
201874.62 %4.63 %9.47 %
201774.3 %17.92 %38.75 %
201675.16 %-0.86 %0.29 %
201568.93 %-30.53 %-24.58 %
201464.77 %-13.12 %-12.15 %
201356.85 %-43.09 %-38.72 %
201260.98 %-47.97 %-38.05 %
201156.44 %-576.44 %-498.22 %
201063.16 %-1,178.95 %-1,075 %
200961.29 %-3,206.45 %-2,822.58 %
2008100 %-233.66 %-233.66 %
200778.71 %-199.65 %-199.65 %
200678.71 %-71.54 %-71.54 %
200578.71 %-35.46 %-35.46 %

Nanosonics Stock Sales Revenue, EBIT, Earnings per Share

The Nanosonics earnings per share therefore indicates how much revenue Nanosonics has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Nanosonics earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Nanosonics's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Nanosonics’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Nanosonics's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Nanosonics Revenue, EBIT and net profit per share

DateNanosonics Sales per ShareNanosonics EBIT per shareNanosonics Earnings per Share
2030e1.11 undefined0 undefined0.27 undefined
2029e0.98 undefined0 undefined0.22 undefined
2028e0.84 undefined0 undefined0.16 undefined
2027e0.78 undefined0 undefined0.11 undefined
2026e0.69 undefined0 undefined0.06 undefined
2025e0.64 undefined0 undefined0.04 undefined
2024e0.56 undefined0 undefined0.03 undefined
20230.54 undefined0.06 undefined0.06 undefined
20220.39 undefined0.01 undefined0.01 undefined
20210.34 undefined0.03 undefined0.03 undefined
20200.33 undefined0.04 undefined0.03 undefined
20190.28 undefined0.05 undefined0.04 undefined
20180.2 undefined0.01 undefined0.02 undefined
20170.22 undefined0.04 undefined0.09 undefined
20160.15 undefined-0 undefined0 undefined
20150.08 undefined-0.03 undefined-0.02 undefined
20140.08 undefined-0.01 undefined-0.01 undefined
20130.06 undefined-0.02 undefined-0.02 undefined
20120.05 undefined-0.03 undefined-0.02 undefined
20110.01 undefined-0.06 undefined-0.05 undefined
20100 undefined-0.04 undefined-0.04 undefined
20090 undefined-0.05 undefined-0.04 undefined
20080.02 undefined-0.04 undefined-0.04 undefined
20070.02 undefined-0.04 undefined-0.04 undefined
20060.02 undefined-0.02 undefined-0.02 undefined
20050.01 undefined-0.01 undefined-0.01 undefined

Nanosonics business model

Nanosonics Ltd is an Australian company specializing in the development of innovative disinfectants designed specifically for use in medical facilities. The company was founded in 2000 by two scientists, Ron Weinberger and Kelvin Trautman, with the aim of reducing the spread of infections through medical devices and equipment. Nanosonics developed a new disinfectant based on the use of ultrasound to achieve higher effectiveness. Its first product, the Trophon EPR, was launched in 2007 and was the world's first Dry Chemical Disinfection system specifically designed for ultrasound probes. Nanosonics has since expanded its product line to include the Trophon2, an improved version of the Trophon EPR, and Ultra, a hand sanitizer for use in medical facilities. It has also developed the TRISTEL Duo disinfection system for flexible endoscopes. Nanosonics is focused on sustainable growth and works closely with customers to develop products tailored to their specific needs. The company is headquartered in Sydney, Australia, with branches in Europe and North America to support global expansion. Technological innovation and collaboration with customers have helped Nanosonics establish itself as a leading provider of disinfection solutions for medical facilities, ensuring patient safety and infection control. Nanosonics is one of the most popular companies on Eulerpool.com.

Nanosonics SWOT Analysis

Strengths

Nanosonics Ltd has a strong brand reputation in the industry, which helps in building customer trust and loyalty.

The company offers innovative and technologically advanced products, giving them a competitive edge in the market.

Their proprietary technology ensures high-quality and efficient disinfection, ensuring customer satisfaction.

Weaknesses

Nanosonics Ltd operates in a highly competitive market, making it challenging to maintain market share and profitability.

The company has a limited product portfolio and may be overly dependent on a single product or market segment.

Their products may have a higher price point compared to competitors, potentially limiting market penetration.

Opportunities

There is a growing global demand for effective infection prevention and control solutions, presenting opportunities for Nanosonics to expand its market reach.

The healthcare sector is constantly evolving, creating opportunities for the development of new products and technologies.

Nanosonics can explore partnerships or collaborations with healthcare organizations to improve market access and distribution channels.

Threats

Intense competition from existing and new players in the industry poses a threat to Nanosonics' market position.

Economic downturns or fluctuations could impact healthcare spending, affecting the demand for Nanosonics' products.

Regulatory changes or compliance requirements may pose challenges for the company in terms of adapting to new standards or obtaining necessary certifications.

Nanosonics historical P/E ratio, EBIT, and P/S ratio.

Nanosonics shares outstanding

The number of shares was Nanosonics in 2023 — This indicates how many shares 306.293 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Nanosonics earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Nanosonics's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Nanosonics’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Nanosonics's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for Nanosonics.

Nanosonics latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
12/31/20230.01 0.02  (85.19 %)2024 Q2
6/30/20230.01 0.03  (108.05 %)2023 Q4
12/31/20220.03 0.03  (12.21 %)2023 Q2
6/30/2022-0.02 -0  (95.05 %)2022 Q4
12/31/20210.01 0.01  (17.12 %)2022 Q2
6/30/20210.01 0.02  (173.81 %)2021 Q4
12/31/20200.02 0.01  (-75.25 %)2021 Q2
12/31/20190.01 0.02  (45.04 %)2020 Q2
6/30/20190.01 0.02  (89.19 %)2019 Q4
12/31/20180.01 0.02  (83.21 %)2019 Q2
1
2

Eulerpool ESG Scorecard© for the Nanosonics stock

Eulerpool World ESG Rating (EESG©)

85/ 100

🌱 Environment

68

👫 Social

99

🏛️ Governance

88

Environment

Scope 1 - Direct Emissions
—
Scope 2 - Indirect emissions from purchased energy
659
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
659
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
✅
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
❌
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
✅

Social

Percentage of female employees42
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept✅
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting✅
Stakeholder Engagement✅
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Nanosonics list of shareholders

%
Name
Stocks
Change
Date
6.29 % Yarra Funds Management Limited19,055,00908/18/2023
6.26 % Stang (Maurie)18,971,517-2008/18/2023
5.49 % First Sentier Investors16,645,6298,640,6632/29/2024
5.42 % ECP Asset Management Pty Ltd16,424,08316,424,0834/16/2024
5.39 % Stang (Bernard)16,333,49308/18/2023
4.91 % Pinnacle Investment Management Group Ltd14,875,501-677,3708/16/2023
4.07 % Selector Funds Management Limited12,320,62412,320,6243/12/2024
2.14 % The Vanguard Group, Inc.6,498,075137,2593/31/2024
2.14 % Kritzler (Steven)6,489,737-1,000,0008/18/2023
1.93 % Australian Foundation Investment Company Ltd5,853,333-116,6678/18/2023
1
2
3
4
5
...
10

Nanosonics Executives and Management Board

Mr. Michael Kavanagh
Nanosonics President, Chief Executive Officer, Managing Director, Executive Director (since 2012)
Compensation 2.04 M
Mr. David Morris
Nanosonics Chief Strategy Officer, Regional President Asia Pacific
Compensation 893,648
Dr. Steven Farrugia
Nanosonics Chief Technology Officer
Compensation 838,421
Mr. Rod Lopez
Nanosonics Chief Operating Officer
Compensation 832,949
Mr. Ken Shaw
Nanosonics Regional President, North America
Compensation 659,223
1
2
3
4

Most common questions regarding Nanosonics

What values and corporate philosophy does Nanosonics represent?

Nanosonics Ltd represents innovation, quality, and a commitment to improving healthcare standards. Their corporate philosophy revolves around providing advanced infection prevention solutions to enhance patient safety and ensure superior medical device reprocessing. Nanosonics is known for developing and commercializing the Trophon® EPR, an environmentally friendly and efficient disinfection system for ultrasound probes. With a strong focus on research and development, Nanosonics strives to deliver cutting-edge technology that meets industry standards and continues to make a positive impact in the healthcare sector.

In which countries and regions is Nanosonics primarily present?

Nanosonics Ltd is primarily present in several countries and regions worldwide. The company has a global presence, with a strong focus on the healthcare sector. Nanosonics products and solutions are widely utilized in healthcare facilities across the United States, Canada, Europe, Asia Pacific countries, and Australia. As a leading global company, Nanosonics Ltd continues to expand its market reach and establish a strong presence in various regions to meet the growing demand for its innovative infection prevention technologies.

What significant milestones has the company Nanosonics achieved?

Nanosonics Ltd has achieved several significant milestones. One notable achievement is the development and commercialization of their pioneering Trophon EPR device. This innovative ultrasound probe disinfection system has revolutionized infection control in healthcare facilities worldwide. Nanosonics Ltd also expanded their global presence by establishing partnerships and securing regulatory approvals in key markets, further enhancing their market position. Additionally, the company has demonstrated consistent growth and financial success over the years, fostering investor confidence. Nanosonics Ltd continues to innovate and drive advancements in the field of infection prevention, cementing their position as a leader in the healthcare industry.

What is the history and background of the company Nanosonics?

Nanosonics Ltd is an Australia-based medical technology company specializing in infection control solutions. Founded in 2001, Nanosonics has become a global leader in developing and commercializing innovative products for healthcare settings. The company's flagship product, Trophon, is a disinfection system for ultrasound probes, effectively preventing the spread of infections. Nanosonics' commitment to research and development has led to numerous awards, recognizing their pioneering technology and dedication to improving patient safety. With a strong focus on quality and customer satisfaction, Nanosonics continues to revolutionize the healthcare industry with their advanced infection prevention solutions.

Who are the main competitors of Nanosonics in the market?

The main competitors of Nanosonics Ltd in the market include companies such as Johnson & Johnson, General Electric Company, Diversey Inc., and Ecolab Inc. These companies compete with Nanosonics Ltd in the healthcare industry, specifically in the field of infection prevention and control. Nanosonics Ltd has established a strong position in the market with its innovative disinfection and decontamination technologies. Despite facing competition from these major players, Nanosonics Ltd continues to differentiate itself through its cutting-edge products and solutions, ensuring healthcare facilities can provide optimal patient care and safety.

In which industries is Nanosonics primarily active?

Nanosonics Ltd is primarily active in the healthcare industry.

What is the business model of Nanosonics?

The business model of Nanosonics Ltd revolves around the development, manufacturing, and distribution of innovative infection prevention solutions for the healthcare industry. Nanosonics specializes in the creation of trophon® EPR, an ultrasound probe disinfection system that effectively eliminates harmful microorganisms, reducing the risk of healthcare-associated infections. By leveraging advanced nanotechnology, Nanosonics aims to provide healthcare professionals with safe, efficient, and cost-effective solutions to enhance patient safety. Through its commitment to delivering cutting-edge sterilization technologies, Nanosonics has established itself as a leading player in the global healthcare sector.

What is the P/E ratio of Nanosonics 2024?

The Nanosonics P/E ratio is 100.57.

What is the P/S ratio of Nanosonics 2024?

The Nanosonics P/S ratio is 5.64.

What is the AlleAktien quality score of Nanosonics?

The AlleAktien quality score for Nanosonics is 4/10.

What is the revenue of Nanosonics 2024?

The expected Nanosonics revenue is 170.45 M AUD.

How high is the profit of Nanosonics 2024?

The expected Nanosonics profit is 9.56 M AUD.

What is the business model of Nanosonics

Nanosonics Ltd is an innovative company specializing in the development and marketing of products in the field of ultrasound disinfection and sterilization. The company was founded in Australia in 2001 and has since become a global leader in this field. Nanosonics Ltd's business model is based on three pillars: research and development, production, and distribution. Research and development: Nanosonics Ltd conducts intensive research and development in collaboration with leading academic and medical institutions around the world. The goal is to develop new technologies and products to make the sterilization and disinfection process more efficient, safer, and environmentally friendly. The company annually invests a high percentage of its revenue in research and development. Production: Nanosonics Ltd manufactures its products in its own factories in Australia and Singapore at the highest technological level. Emphasis is placed on quality, reliability, and sustainability. The company utilizes modern manufacturing processes and maintains high standards for quality control and safety testing in the production process. Nanosonics Ltd places great importance on implementing green technologies in its production and operations. Distribution: Nanosonics Ltd distributes its products internationally in collaboration with partners, dealers, and distributors. The focus is on industrialized countries such as the USA, Europe, Australia, and Japan. The company employs an intensive marketing and distribution strategy to strengthen its presence in global markets. The focus is on close collaboration with customers to better understand their needs and requirements, thus being able to offer tailor-made solutions for their specific applications. Nanosonics Ltd's products: Currently, the company offers two products for ultrasound disinfection and sterilization. These are the Trophon EPR and Trophon2. Both products have been specifically developed for medical use to provide the highest level of safety around the patient. The Trophon EPR and Trophon2 offer a comprehensive solution for the complete cleaning and disinfection of ultrasound probes in medical practice. The products utilize Trophon technology to ensure effective, fast, and safe sterilization that can be reliably performed even under highly demanding conditions. In addition to the readiness and effectiveness of the products, Nanosonics Ltd focuses on environmentally friendly manufacturing. The products are designed to comply with strict environmental and safety standards and reduce CO2 emissions. Preserving the environment is always one of Nanosonics Ltd's central goals alongside safety. With Nanosonics Ltd's products, the medical world is always one step ahead in the fight against infections and sterilized equipment. The Trophon EPR and Trophon2 are examples of Nanosonics Ltd's innovative technologies that solve complex sanitary problems and elevate environmentally friendly technologies to a new level.

What is the Nanosonics dividend?

Nanosonics pays a dividend of 0 AUD distributed over payouts per year.

How often does Nanosonics pay dividends?

The dividend cannot currently be calculated for Nanosonics or the company does not pay out a dividend.

What is the Nanosonics ISIN?

The ISIN of Nanosonics is AU000000NAN9.

What is the Nanosonics WKN?

The WKN of Nanosonics is A0MQVE.

What is the Nanosonics ticker?

The ticker of Nanosonics is NAN.AX.

How much dividend does Nanosonics pay?

Over the past 12 months, Nanosonics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Nanosonics is expected to pay a dividend of 0 AUD.

What is the dividend yield of Nanosonics?

The current dividend yield of Nanosonics is .

When does Nanosonics pay dividends?

Nanosonics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Nanosonics?

Nanosonics paid dividends every year for the past 0 years.

What is the dividend of Nanosonics?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Nanosonics located?

Nanosonics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Nanosonics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Nanosonics from 8/1/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 8/1/2024.

When did Nanosonics pay the last dividend?

The last dividend was paid out on 8/1/2024.

What was the dividend of Nanosonics in the year 2023?

In the year 2023, Nanosonics distributed 0 AUD as dividends.

In which currency does Nanosonics pay out the dividend?

The dividends of Nanosonics are distributed in AUD.

All fundamentals about Nanosonics

Our stock analysis for Nanosonics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nanosonics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.